Edition:
United Kingdom

Takeda And Hemoshear Therapeutics Extend Exclusive Drug Discovery Partnership In Liver Diseases


Wednesday, 20 Mar 2019 

March 20 (Reuters) - Takeda Pharmaceutical Co Ltd <4502.T>::TAKEDA AND HEMOSHEAR THERAPEUTICS EXTEND EXCLUSIVE DRUG DISCOVERY PARTNERSHIP IN LIVER DISEASES.HEMOSHEAR THERAPEUTICS- HEMOSHEAR WAS ELIGIBLE TO RECEIVE MILESTONE PAYMENTS OF POTENTIALLY $470 MILLION AND ROYALTIES.HEMOSHEAR THERAPEUTICS- FURTHER ADDITIONAL FINANCIAL TERMS RELATED TO EXTENSION OF PARTNERSHIP WERE NOT DISCLOSED.